Equities

Sanofi India Ltd

SANOFI:NSI

Sanofi India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)7,205.30
  • Today's Change21.30 / 0.30%
  • Shares traded2.98k
  • 1 Year change+62.10%
  • Beta0.6086
Data delayed at least 15 minutes, as of Sep 20 2024 06:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,94510,04915,380
Total Receivables, Net1,6711,6801,788
Total Inventory6,6544,1353,963
Prepaid expenses718151
Other current assets, total139158197
Total current assets12,48016,10321,379
Property, plant & equipment, net3,2333,2403,417
Goodwill, net--00
Intangibles, net755152
Long term investments------
Note receivable - long term1,2531,1845,710
Other long term assets678013
Total assets17,14820,71730,610
LIABILITIES
Accounts payable2,9153,5643,767
Accrued expenses9281,0831,064
Notes payable/short-term debt000
Current portion long-term debt/capital leases518770
Other current liabilities, total2,6192,6722,595
Total current liabilities6,5137,4067,496
Total long term debt139149176
Total debt190236246
Deferred income tax374963
Minority interest------
Other liabilities, total307355619
Total liabilities6,9967,9598,354
SHAREHOLDERS EQUITY
Common stock230230230
Additional paid-in capital202020
Retained earnings (accumulated deficit)9,90212,50822,006
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity10,15212,75822,256
Total liabilities & shareholders' equity17,14820,71730,610
Total common shares outstanding232323
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.